Inhaled colistin for lower respiratory tract infections

Bibliography

• Kumarasamy KK, Toleman MA, Walsh TR, Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10(9):597-602
   PubMed Web of Science ®Google Scholar
• Fujitani S, Fujitani S, Sun HY, Pneumonia due to Pseudomonas aeruginosa. Chest 2010;139(4):909-19
   Web of Science ®Google Scholar
• Bergogne-Berezin E, Towner KJ, Acinetobacter spp. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9(2):148-65
   PubMed Web of Science ®Google Scholar
• Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50(6):1953-8
   PubMed Web of Science ®Google Scholar
• Orwa JA, Govaerts C, Busson R, Isolation and structural characterization of colistin components. J Antibiot (Tokyo) 2001;54(7):595-9
   PubMed Web of Science ®Google Scholar
• Orwa JA, Govaerts C, Gevers K, Study of the stability of polymyxins B(1), E(1) and E(2) in aqueous solution using liquid chromatography and mass spectrometry. J Pharm Biomed Anal 2002;29(1-2):203-12
   PubMed Web of Science ®Google Scholar
• Falagas M, Kasiakou SK, Tsiodras S, Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically Ill patients:a review of the recent literature. Clin Med Res 2006;4(2):138-46
   PubMedGoogle Scholar
• Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999;43(6):1317-23
   PubMed Web of Science ®Google Scholar
• Dhand R. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir Care 2007;52(7):866-84
   PubMed Web of Science ®Google Scholar
• Kesser KC, Geller DE. Aerosol antibiotics in cystic fibrosis. Respir Care 2009;54(5):658-70
   PubMed Web of Science ®Google Scholar
• Kesser KC, Geller DE. New aerosol delivery devices for cystic fibrosis. Respir Care 2009;54(6):754-67. discussion 767-8.
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Papadakis E. Inhaled anti-infective agents: emphasis on colistin. Infection 2010;38(2):81-8
   PubMed Web of Science ®Google Scholar
• Montero A, Ariza J, Corbella X, Domenech A, Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2002;46(6):1946-52
   PubMed Web of Science ®Google Scholar
• Montero A, Ariza J, Corbella X, Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother 2004;54(6):1085-91
   PubMed Web of Science ®Google Scholar
• Chiang SR, Chuang YC, Tang HJ, Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Crit Care Med 2009;37(9):2590-5
   PubMed Web of Science ®Google Scholar
• Lu Q, Girardi C, Zhang M, Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 2010;36(7):1147-55
   PubMed Web of Science ®Google Scholar
• Herrmann G, Yang L, Wu H, Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis 2010;202(10):1585-92
   PubMed Web of Science ®Google Scholar
• Ratjen F, Rietschel E, Kasel D, Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006;57(2):306-11
   PubMed Web of Science ®Google Scholar
• Jensen T, Pedersen SS, Garne S, Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987;19(6):831-8
   PubMed Web of Science ®Google Scholar
• Westerman EM, Le Brun PP, Touw DJ, Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study. J Cyst Fibros 2004;3(1):23-8
   PubMedGoogle Scholar
• Perpati G, Pouliou E, Stefanatou E, Long-term effect of inhaled colomycin on exercise capacity in adult patients with cystic fibrosis. J Cyst Fibros 2005;4(Suppl):S54
   Google Scholar
• Nikonova V, Zhekayte E, Kapranov N. Efficacy and safety of colistin for inhalation in children 5 years old and younger with cystic fibrosis with Pseudomonas aeruginosa infection. J Cyst Fibros 2005;4(Suppl):S100
   Google Scholar
• Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23(5):330-5
   PubMed Web of Science ®Google Scholar
• Hodson ME, Gallagher CG, Govan JR. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 2002;20(3):658-64
   PubMed Web of Science ®Google Scholar
• Westerman EM, de Boer AH, Le Brun PP, Dry powder inhalation of colistin sulphomethate in healthy volunteers: a pilot study. Int J Pharm 2007;335(1-2):41-5
   PubMed Web of Science ®Google Scholar
• Westerman EM, De Boer AH, Le Brun PP, Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study. J Cyst Fibros 2007;6(4):284-92
   PubMed Web of Science ®Google Scholar
• Berlana D, Llop JM, Manresa F, Jodar R. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Pharmacotherapy 2010;31(2):146-57
   Web of Science ®Google Scholar
• Steinfort DP, Steinfort C. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Intern Med J 2007;37(7):495-8
   PubMed Web of Science ®Google Scholar
• Green ST, Nathwani D, Gourlay Y, Nebulized colistin (polymyxin E) for AIDS-associated Pseudomonas aeruginosa pneumonia. Int J STD AIDS 1992;3(2):130-1
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Kasiakou SK, Mastora Z, Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9(1):R53-9
   PubMed Web of Science ®Google Scholar
• Falagas ME, Siempos II, Rafailidis PI, Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Respir Med 2009;103(5):707-13
   PubMed Web of Science ®Google Scholar
• Korbila IP, Michalopoulos A, Rafailidis PI, Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect 2010;16(8):1230-6
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Fotakis D, Virtzili S, Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram-negative bacteria: a prospective study. Respir Med 2008;102(3):407-12
   PubMed Web of Science ®Google Scholar
• Ghannam DE, Rodriguez GH, Raad II, Inhaled aminoglycosides in cancer patients with ventilator-associated gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis 2009;28(3):253-9
   PubMed Web of Science ®Google Scholar
• Kofteridis DP, Alexopoulou C, Valachis A, Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 2010;51(11):1238-44
   PubMed Web of Science ®Google Scholar
• Montero M, Horcajada JP, Sorli L, Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Infection 2009;37(5):461-5
   PubMed Web of Science ®Google Scholar
• Falagas ME, Sideri G, Korbila IP, Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol 2010;45(11):1135-40
   PubMed Web of Science ®Google Scholar
• Nakwan N, Wannaro J, Thongmak T, Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 2010;46(1):60-6
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Wannaro J, Thongmak T, Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36(9):1111-18
   PubMed Web of Science ®Google Scholar
• Markou N, Apostolakos H, Koumoudiou C, Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 2003;7(5):R78-83
   PubMed Web of Science ®Google Scholar
• Linden PK, Kusne S, Coley K, Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003;37(11):e154-60
   PubMed Web of Science ®Google Scholar
• Kasiakou SK, Michalopoulos A, Soteriades ES, Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005;49(8):3136-46
   PubMed Web of Science ®Google Scholar
• Reed MD, Stern RC, O'Riordan MA, The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001;41(6):645-54
   PubMed Web of Science ®Google Scholar
• Whitaker P, Lavergne S, Gooi J, Prevalence and mechanism of adverse reactions to colistin in patients with cystic fibrosis. J Cyst Fibros 2005;4(Suppl):S50
   Google Scholar
• Cunningham S, Prasad A, Collyer L, Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch Dis Child 2001;84(5):432-3
   PubMed Web of Science ®Google Scholar
• Dodd ME, Abbott J, Maddison J, Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis. Thorax 1997;52(7):656-8
   PubMed Web of Science ®Google Scholar
• Eggleston PA, Rosenstein BJ, Stackhouse CM, Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease. Chest 1988;94(2):360-5
   PubMed Web of Science ®Google Scholar
• Alothman GA, Ho B, Alsaadi MM, Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 2005;127(2):522-9
   PubMed Web of Science ®Google Scholar
• Jones A, Elphick H, Pettitt E, Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase. Eur Respir J 2002;19(6):1136-41
   PubMed Web of Science ®Google Scholar
• Hector A, Kappler M, Griese M. In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients. Mediators Inflamm 2010:809591
   PubMedGoogle Scholar